The latest strain of the COVID-19 virus, XEC, is circulating across the country. The new variant has been reported in at ...

SPIKEVAX® is the first updated COVID-19 vaccine authorized in Canada for 2024-2025, offering a timely solution to help protect Canadians ...

Health Canada authorized Moderna's updated COVID-19 vaccine that protects against currently circulating variants of the virus ...

Moderna (MRNA) plans to launch a skin cancer vaccine developed with Merck (MRK) in 2025, but faces stock pressure after ...

Moderna will slash five clinical programmes but says it remains on track for ten product approvals in the next three years.

US mRNA specialist Moderna’s shares fell 18% after updates at its R&D day. The company plans to focus on 10 product approvals ...

Moderna plans to cut $1.1bn in costs by 2027, pausing and scrapping several R&D programs. See why I think further downside ...

Focuses on ten product approvals through 2027Expects to submit next-generation COVID vaccine for approval in 2024Expects to submit flu/COVID ...

Moderna said the changes will reduce the cumulative spend on R&D between 2025 and 2028 to $16 billion from $20 billion, and ...

Focuses on ten product approvals through 2027Expects to submit next-generation COVID vaccine for approval in 2024Expects to submit flu/COVID combination vaccine for approval in 2024Announces positive ...

On August 22, Moderna announced that FDA approved its supplemental Biologics License Application (“sBLA”) for a new formula of their COVID-19 vaccine, SPIKEVAX®, for individuals 12 years old ...

Erik ten Hag has the full backing of Manchester United's new leadership team, according to chief executive Omar Berrada. United triggered a one-year extension to Ten Hag's contract in the summer ...